Abstract
Gynecological cancers represent cancers arising from the female genital tract. The most common cancer in female genital tract is carcinoma cervix. Carcinoma cervix is preceded by precancerous lesions, which can be detected by screening tests such as cervical Pap smear and HPV detection. Endometrial carcinoma is usually detected on endometrial curettings or biopsy, as endometrial aspiration cytology is not reliable. Cervical smear may occasionally represent cells arising from endometrial carcinoma. Majority of ovarian tumors are epithelial tumors, papillary serous carcinoma being the most common. Although FNAC in ovarian neoplasms is not a preferred technique, the same may be performed in young females as initial work-up, in advanced ovarian malignancies, and in the follow-up of patients after chemotherapy or radiotherapy. This chapter includes pathology of gynecological cancers and cytological evaluation of the same such as cervical Pap test for cervical carcinomas and fine needle aspiration cytology mainly for ovarian tumors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AGCT:
-
Adult granulosa cell tumor
- AIS:
-
Adenocarcinoma in situ
- CCC:
-
Clear cell carcinoma
- CEA:
-
Carcinoembryonic antigen
- CIN:
-
Cervical intraepithelial neoplasia
- CIS:
-
Carcinoma in-situ
- CK:
-
Cytokeratin
- ESS:
-
Endometrial stromal sarcoma
- FDA:
-
Food and drug administration
- FNAC:
-
Fine needle aspiration cytology
- H&E:
-
Hematoxylin and Eosin stain
- HPV:
-
Human papilloma virus
- HSIL:
-
High grade squamous intraepithelial lesions
- JGCT:
-
Juvenile granulosa cell tumor
- LBC:
-
Liquid based cytology
- LMS:
-
Leiomyosarcoma
- LSIL:
-
Low-grade squamous intraepithelial lesions
- MGG:
-
May Grünwald Geimsa stain
- MMMT:
-
Malignant mixed müllerian tumor
- Pap:
-
Papanicolaou stain
- PAS:
-
Periodic acid-Schiff’s stain
- PCR:
-
Polymerase chain reaction
- SCC:
-
Squamous cell carcinoma
- SIL:
-
Squamous intraepithelial lesions
- STIC:
-
Serous tubal intra-epithelial carcinoma
- TBS:
-
The Bethesda System
- VIA:
-
Visual inspection using acetic acid
- VILI:
-
Visual inspection using Lugol’s iodine
References
Ferlay J, Shin H-R, Bray F, Forman D, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.
Arulponni TR, Janaki MG, Nirmala S, Ramesh BS, Rishi KS, Kirthi K. Carcinoma cervix treated with radiotherapy—our experience with emphasis on our concern. J Obstet Gynaecol India. 2010;60:61–5.
Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12:186–92.
Holowaty P, Miller AB, Rohan T, et al. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999;91:252.
Colgan TJ, Lickrish GM. The topography and invasive potential of cervical adenocarcinoma in situ, with and without associated squamous dysplasia. Gynecol Oncol. 1990;36:246–9.
Denehy TR, Gregori CA, Breen JL. Endocervical curettage, cane margins, and residual adenocarcinoma in situ of the cervix. Obstet Gynecol. 1997;90:1–6.
Ursin G, Pike MC, Preston-Martin S, et al. Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix, results from a population based case– control study. Cancer Causes Control. 1996;7:391–401.
Gupta N, Srinivasan R, Rajwanshi A. Functional biomarkers in cervical precancer: an overview. Diagn Cytopathol. 2010;38:618–23.
Gupta N, Desai M. New technologies in cervical cancer screening. BIDA AGM. 2011;18:5–6.
Ridder R, Luyten A, Scherbring S, Reinecke-Luettge A, Schmidt D, Petry KU. Triaging PAP negative, HPV positive cervical cancer screening test results by p16/Ki67 dual stained cytology. Acta Cytol. 2010;54(3):404–5.
National Institute for Clinical Excellence (NICE). NHS Technology Appraisal Guidance 69. Guidance on the use of liquid-based cytology (LBC) for cervical screening. London: National Institute for Clinical Excellence; 2003.
Utagawa ML, Pereira SM, Makabe S, et al. Pap test in a high risk population comparison of conventional and liquid-based cytology. Diagn Cytopathol. 2004;31:169–72.
Strander B, Andersson-Ellstrom A, Milsom I, et al. Liquid-based cytology versus conventional papanicolaou smear in an organized screening program. Cancer Cytopathol. 2007;111:285–91.
Schledermann D, Ejersbo D, Hoelund B. Improvement of diagnostic accuracy and screening conditions with liquid-based cytology. Diagn Cytopathol. 2006;34:780–5.
Confortini M, Bergeron C, Desai M, et al. Accuracy of liquid-based cytology. Cancer. 2010;118:203–8.
Siebers AG, Klinkhamer PJJM, Grefte JMM, et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors. JAMA. 2009;302:1757–64.
Farthing A, Masterson P, Mason WP, Vousden KH. Human papillomavirus detection by hybrid capture & it’s possible clinical use. J Clin Pathol. 1994;47:649–52.
Ergünay K. Detection and typing of human Papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities. Mikrobiyol Bull. 2008;42:273–82.
Hubbard RA. Human papillomavirus testing methods. Arch Pathol Lab Med. 2003;127:940–5.
Gupta N, Dudding N, Smith JHF. Cytomorphological features of extra-genital metastases in SurePathâ„¢ cervical liquid-based cytology: a series of eight cases. Cytopathology 2012; doi: 10.1111/j.1365-2303.2011.00945.x.
Liu FS. Molecular carcinogenesis of endometrial cancer. Taiwan J Obstet Gynecol. 2007;46:26–32.
Sherman ME, Bur ME, Kurman RJ. p53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesis. Hum Pathol. 1995;26:1268–74.
Mutter GL. PTEN, a protean tumor suppressor. Am J Pathol. 2001;158:1895–8.
Matias-Guiu X, Catasus L, Bussaglia E, et al. Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol. 2001;32:569–77.
Cherkis RC, Patten Jr SF, Andrews TJ, Dickinson JC, Patten FW. Significance of normal endometrial cells detected by cervical cytology. Obstet Gynecol. 1988;71:242–4.
DuBeshter B, Warshol DP, Angel C, Dvoretsky PM, Lin JY, Raubertas RF. Endometrial carcinoma: the relevance of cervical cytology. Obstet Gynecol. 1991;77:458–62.
Ronneett BM, Zaino RJ, Ellenson LH, Kurman RJ. Endometrial carcinoma. In: Kurman RJ, editor. Blaustein’s pathology of the female genital tract. 5th ed. New Delhi: Springer; 2004. p. 501–59.
Gupta N, Awasthi A, Rajwanshi A, Malhotra S. Fine needle aspiration cytology of low grade endometrial stromal sarcoma—a case report. Acta Cytol. 2007;51(3):461–3.
Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ. World Health Organization international histological classification of tumors: histological typing of female genital tract tumors. 2nd ed. Berlin: Springer; 1994.
Auersperg N. Origin of ovarian carcinomas: a unifying hypothesis. Int J Gynaecol Pathol. 2010;30:12–21.
Murthy NS, Shalini S, Suman G. Changing trends in incidence of ovarian cancer—the Indian scenario. Asian Pac J Cancer Prev. 2009;10:1025–30.
Layfield LJ, Berek JS. Fine-needle aspiration cytology in the management of gynecologic oncology patients. Cancer Treat Res. 1994;70:1–13.
Kurman RJ, Shih leM. The origin and pathogenesis of epithelial ovarian cancer—a proposed unifying theory. Am J Surg Pathol. 2010;34:433–43.
Partridge EE, Phillips JL, Menck HR. The National Cancer Data Base report on ovarian cancer treatment in United States hospitals. Cancer. 1996;78:2236–46.
Komiyama S, Aoki D, Tominaga E, Susumu N, Udagawa Y, Nozawa S. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation. Gynecol Oncol. 1999;72:342–6.
Yoshikawa H, Jimbo H, Okada S, Matsumoto K, Onda T, Yasugi T, Taketani Y. Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest. 2000;50:11–7.
Ramalingam P, Malpica A, Silva EG, Gershenson DM, Liu JL, Deavers MT. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Am J Surg Pathol. 2004;28:1499–505.
Dharan M. Intra-operative cytology of small cell carcinoma of the ovary with hypercalcemia: a case report. Acta Cytol. 1993;37:61–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gupta, N., Rajwanshi, A. (2013). Gynecological Cancers: Pathology and Cytological Methods for Diagnosis of Gynecological Cancers. In: Shetty, M. (eds) Breast and Gynecological Cancers. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1876-4_3
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1876-4_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-1875-7
Online ISBN: 978-1-4614-1876-4
eBook Packages: MedicineMedicine (R0)